ID: ALA443359
Chembl Id: CHEMBL443359
PubChem CID: 24813131
Max Phase: Preclinical
Molecular Formula: C9H20N4O3
Molecular Weight: 232.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(N)NCCCN1C[C@H](O)[C@H](O)[C@H]1CO
Standard InChI: InChI=1S/C9H20N4O3/c10-9(11)12-2-1-3-13-4-7(15)8(16)6(13)5-14/h6-8,14-16H,1-5H2,(H4,10,11,12)/t6-,7+,8-/m1/s1
Standard InChI Key: SRVFEOTUDNUOFZ-GJMOJQLCSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 232.28 | Molecular Weight (Monoisotopic): 232.1535 | AlogP: -2.74 | #Rotatable Bonds: 5 |
| Polar Surface Area: 125.83 | Molecular Species: BASE | HBA: 5 | HBD: 6 |
| #RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 13.34 | CX Basic pKa: 12.13 | CX LogP: -3.18 | CX LogD: -6.13 |
| Aromatic Rings: ┄ | Heavy Atoms: 16 | QED Weighted: 0.17 | Np Likeness Score: 1.08 |
| 1. Goeminne A, McNaughton M, Bal G, Surpateanu G, Van Der Veken P, De Prol S, Versées W, Steyaert J, Haemers A, Augustyns K.. (2008) Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors., 43 (2): [PMID:17582660] [10.1016/j.ejmech.2007.03.027] |
| 2. Berg M, Kohl L, Van der Veken P, Joossens J, Al-Salabi MI, Castagna V, Giannese F, Cos P, Versées W, Steyaert J, Grellier P, Haemers A, Degano M, Maes L, de Koning HP, Augustyns K.. (2010) Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis., 54 (5): [PMID:20194690] [10.1128/aac.01787-09] |
Source(1):
